SharpLight Israel ‘ Receives FDA clearance for Med Aesthetic Platforms

 

Rishon Le-Zion, Israel, December 21,2011 —

 

SharpLight Israel has received the prestigious FDA clearance for all its devices and indications (excluding SharpLight Israel’s unique RF technology, which is pending). The FDA clearance is the company’s 15^th  international regulative procedure to be successfully completed, a mark of the company’s technological, R & D and manufactuing excellence.